Wash. Admin. Code § 182-50-200

Current through Register Vol. 24-12, June 15, 2024

Section 182-50-200 - Endorsing practitioner therapeutic interchange program; effect of practitioner's endorsing status; dispense as written instructions

(1) When filling prescriptions for participating state purchased health care programs, pharmacists must make a therapeutic interchange if the prescription is prescribed by an endorsing practitioner except:

(a) If the endorsing practitioner indicates "dispense as written" on the nonpreferred prescription;

(b) If the prescription is a refill of an antipsychotic, anti-depressant, antiepileptic, chemotherapy, antiretroviral, immunosuppressive drug, or an immuno-modulator/antiviral treatment for hepatitis C ; or

(c) If the pharmacy and therapeutics committee has determined that therapeutic interchange is not clinically appropriate for a specific drug or drug class on the Washington preferred drug list.

(2) When a therapeutic interchange is made, the pharmacist must notify the endorsing practitioner of the specific drug and dose dispensed.

Wash. Admin. Code § 182-50-200

Amended by WSR 16-16-083, Filed 7/29/2016, effective 8/29/2016

Statutory Authority: RCW 41.05.160 and 69.41.180. 07-19-031 (Order 07-03), § 182-50-200, filed 9/12/07, effective 10/13/07. Statutory Authority: RCW 41.05.160; 2004 1st sp.s. c 29 § 10. 04-06-021 (Order 03-02), § 182-50-200, filed 2/23/04, effective 3/25/04.